The outcome of cochlear implantation (CI) was favorable (Fig. 3), indicating that CI affords a good treatment option for the patients with severe-profound MYO7A-associated HL in all hereditary forms. The gene discussed is MYO7A; the disease is Hodgkins lymphoma.